Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
Prescription Drugs
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: A Look at Florida’s Decade-Long Effort to Curb the Opioid Epidemic A Look at Florida’s Decade-Long Effort to Curb the Opioid Epidemic
Over the years, Florida has implemented legal and regulatory responses to the opioid epidemic that have been met with both success and continued challenges.
-
Read more: The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing The Promise and Pitfalls of Trump’s “Most Favored Nation” Approach to Drug Pricing
A recent executive order aimed at addressing ballooning pharmaceutical expenditures is ambitious in scope, but its impact remains to be seen.
-
Read more: How Policies Enacted During COVID-19 Might Reduce Future Drug Spending How Policies Enacted During COVID-19 Might Reduce Future Drug Spending
A positive outcome of the pandemic may be the demonstration via emergency measures that state governments can be flexible in substitution policies.
-
Read more: New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs
Pandemics like COVID-19 certainly require the prompt approval of treatments, but efficacy and safety should not come at the cost of speed.
-
Read more: Overdose Update: Celebrity Edition Overdose Update: Celebrity Edition
By Scott Burris You’ve probably heard about the good news/bad news experience of Stephanie Bongiovi, daughter of rocker Jon Bon Jovi. A college student, she ODed on heroin, but help was summoned and she’s going to be fine. The (temporary) bad news for her (and longer term for others in her plight) is that she and…